Latest Director Loans News

Stavely Minerals has locked in a $500,000 unsecured director loan facility to fund its 2026 Scoping Study targeting copper, gold, and silver production. This non-dilutive funding move underscores confidence from within the board as the company advances key projects.

Wellnex Life Limited is exploring acquisition interest and convertible note funding to accelerate Pain Away's expansion and strengthen its financial footing, signaling a pivotal phase in its turnaround journey.

C29 Metals is progressing drilling plans at its Samsons Tank Copper project in NSW while securing a $150,000 convertible loan from a director and exploring global acquisition opportunities to diversify its portfolio.

Careteq Limited reported a disciplined operating cash flow in Q2 FY26 with strong growth in its Embedded Health Solutions segment and ongoing resolution of an ATO tax incentive dispute.

Cullen Resources Limited has outlined an active exploration agenda for early 2026, advancing drilling programs across its gold and base metal projects in Western Australia and Finland while maintaining a stable financial footing.

Range International Limited has reported its strongest quarterly sales and production figures yet in Indonesia, while strategically pivoting towards a pallet rental model to secure more stable revenue streams.

Jade Gas Holdings reported continuous gas production from two wells at its Red Lake coal bed methane project in Mongolia during Q4 2025, confirming commercial viability with exceptionally high methane purity. The company also secured a $70 million non-binding LOI and appointed a new CEO to drive development.

Genmin Limited has completed a A$25.7 million placement, cleared its debt, and made significant strides in financing its Baniaka iron ore project in Gabon, including a strategic partnership with Chinese SOE SHICO.

Freedom Care Group Holdings has revealed ongoing financial distress with key subsidiaries entering liquidation and persistent delays in payments from the NDIA, leaving the company with a diminished cash reserve and a strategic focus on asset sales and cost reduction.

Zelira Therapeutics has raised nearly US$33 million to fund clinical trials for its HOPE 1 cannabinoid-based medicine targeting autism, while also benefiting from a $1.07 million R&D tax refund.

Empire Resources has reported promising drill results from its Yuinmery Copper-Gold Project, revealing high-grade mineralisation and new gold prospects, while awaiting assay results from Pennys Gold drilling.

Genmin Limited has completed a A$25.7 million capital raise, wiping out its debt and positioning itself to accelerate development of its flagship Baniaka iron ore project in Gabon.